Journal of the American Society of Nephrology, Vol 4, 1306-1315, Copyright © 1993 by American Society of Nephrology

REGULAR ARTICLES

Efficacy of area under the curve cyclosporine monitoring in renal transplantation

MM Meyer, M Munar, J Udeaja and W Bennett
Division of Nephrology, Hypertension and Clinical Pharmacology, Oregon Health Sciences University, Portland.

Previous studies suggest that area-under-the-curve (AUC) pharmacokinetic monitoring is superior to trough level monitoring for proper cyclosporin A (CSA) dosing, but AUC monitoring is expensive and unwieldy. The utility of a simplified AUC monitoring method was evaluated for predicting AUC on the basis of three timed levels. CSA pharmacokinetic profiles were studied in 27 renal transplant patients at steady state early (days), late (months), and in some patients, serially posttransplantation. Whole-blood RIA levels were obtained at 2, 4, 6, 10, 12, 14, and 24 h after a once-daily CSA dose. The 6- and 24-h levels were the best single-level predictors of AUC (r = 0.77 and 0.76, respectively). The best model predictive of AUC curves used three time points at 2, 6, and 24 h postdose: AUC predicted = 8.6 x (24 h) + 1.4 x (2 h) + 6.2 x (6 h) + 1.57 mg x h/L; r2 = 0.986, P = 0.00001. The greatest pharmacokinetic variability occurred between 0 and 10 h postdose (absorption and distribution) between patients and even within individual patients monitored serially over time. The 12- to 24-h postdose portion (elimination) of the curve was consistently flat and uniform among patients. AUC were not consistent in individual patients over time. An AUC of more than 13 mg x h/L correlated with nephrotoxicity, whereas a value of 8 mg x h/L correlated with protection from rejection in first-transplant recipients. This AUC, however, was not able to prevent rejection in reengrafted or highly sensitized patients.

This article has been cited by other articles:

				A. T. Rowshani, E. M. Scholten, F. Bemelman, M. Eikmans, M. Idu, M. C.R. van Groningen, J. S. Surachno, M. J.K. Mallat, L. C. Paul, J. W. de Fijter, et al. No Difference in Degree of Interstitial Sirius Red-Stained Area in Serial Biopsies from Area under Concentration-over-Time Curves-Guided Cyclosporine versus Tacrolimus-Treated Renal Transplant Recipients at One Year J. Am. Soc. Nephrol., January 1, 2006; 17(1): 305 - 312. [Abstract] [Full Text] [PDF]

				S. C. L. M. Cremers, E. M. Scholten, R. C. Schoemaker, E. G. W. M. Lentjes, P. Vermeij, L. C. Paul, J. den Hartigh, and J. W. de Fijter A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas-kidney transplant recipients Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1201 - 1208. [Abstract] [Full Text] [PDF]

				B. L. KASISKE, M. A. VAZQUEZ, W. E. HARMON, R. S. BROWN, G. M. DANOVITCH, R. S. GASTON, D. ROTH, J. D. SCANDLING JR., and G. G. SINGER Recommendations for the Outpatient Surveillance of Renal Transplant Recipients J. Am. Soc. Nephrol., October 1, 2000; 11(2007): S1 - S86. [Abstract] [Full Text] [PDF]

				B. D. KAHAN, M. WELSH, D. L. URBAUER, M. B. MOSHEIM, K. M. BEUSTERIEN, M. R. WOOD, L. P. SCHOENBERG, J. DICESARE, S. M. KATZ, and C. T. VAN BUREN Low Intraindividual Variability of Cyclosporin A Exposure Reduces Chronic Rejection Incidence and Health Care Costs J. Am. Soc. Nephrol., June 1, 2000; 11(6): 1122 - 1131. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673